(Q37383598)

20 August 2017

Antimalarial peptides from marine cyanobacteria: isolation and structural elucidation of gallinamide A. (English)

1 reference

20 August 2017

0 references

1 reference

Benjamin R Clark

2

0 references

Roger G Linington

object named as

Roger G Linington

1

0 references

Dennis E Kyle

object named as

Dennis E Kyle

6

0 references

William H. Gerwick

7

object named as

William H Gerwick

1 reference

20 August 2017

Erin E Trimble

3

1 reference

20 August 2017

Alejandro Almanza

4

1 reference

20 August 2017

Luis-David Ureña

5

1 reference

20 August 2017

31 December 2008

1 reference

Crossref

full work available at URL

16 September 2022

https://europepmc.org/articles/pmc2760338?pdf=render

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1021/np8003529?email=unpaywall_01@example.com

published in

Journal of Natural Products

1 reference

20 August 2017

72

1 reference

20 August 2017

1

1 reference

20 August 2017

14-17

1 reference

https://api.unpaywall.org/v2/10.1021/np8003529?email=unpaywall_01@example.com

20 August 2017

1 reference

19 March 2024

access restriction status

open access

1 reference

inferred from online access status

cites work

Drug discovery for malaria: a very challenging and timely endeavor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Biogenetic diversity of cyanobacterial metabolites

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

The manzamines as an example of the unique structural classes available for the discovery and optimization of infectious disease controls based on marine natural products

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Bioactive natural products from marine cyanobacteria for drug discovery

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Venturamides A and B: antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Antiplasmodial marine natural products in the perspective of current chemotherapy and prevention of malaria: a review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Antimalarial potential of xestoquinone, a protein kinase inhibitor isolated from a Vanuatu marine sponge Xestospongia sp.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Virtual drug discovery and development for neglected diseases through public-private partnerships

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Nitrogen-containing metabolites from marine cyanobacteria

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Glidobactins A, B and C, new antitumor antibiotics. I. Production, isolation, chemical properties and biological activity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Absolute stereochemistry of citrinadins a and B from marine-derived fungus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Potential antimalarial lead structures from fungi of marine origin

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2760338

Malevamide D: isolation and structure determination of an isodolastatin H analogue from the marine cyanobacterium Symploca hydnoides

2 October 2018

1 reference

12 December 2020

Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum

1 reference

12 December 2020

Glidobactins D, E, F, G and H; minor components of the antitumor antibiotic glidobactin

1 reference

12 December 2020

Structures of cepafungins I, II and III

1 reference

12 December 2020

Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides

1 reference

12 December 2020

Glidobactins A, B and C, new antitumor antibiotics. I. Production, isolation, chemical properties and biological activity.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1331

Identifiers

DOI

10.1021/NP8003529

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19161344

1 reference